Azilsartan (medoxomil) - CAS# 863031-21-4 L 13-27 GTS-21 bound to human α4β2

GTS-21 bound to human α4β2 nAChR (Ki=20 nM) 100-fold more potently than to humanα7-nAChR

Erlotinib HCl (1 μM) induces apoptosis in DiFi humancolon cancer cells

InChi: InChI=1S/C20H24O4/c1-13(8-15-4-6-17(21)19(10-15)22-3)14(2)9-16-5-7-18-20(11-16)24-12-23-18/h4-7

1158/0008-5472

brasofensine

Azilsartan (medoxomil) - CAS# 863031-21-4 L 13-27 GTS-21 bound to human α4β2Azilsartan medoxomil also known as TAK 491, is an orally administered angiotensin II receptor type 1 antagonist (blocker) used in the treatment of adults with essential hypertension. Azilsartan medoxomil is a useful and attractive new option for lowering BP in patients with essential hypertension, particularly for those not able to tolerate other antihypertensive drugs. Further studies are required to evaluate the effects of azilsartan medoxomil on